Affiliated Faculty
This list of affiliated investigators can help you identify potential research mentors at the University of Pittsburgh. PSTP students can, and do, work with mentors not on this list, but the investigators featured below have expressed interest in hosting PSTP students in their laboratories.
Brain tumors, hydrocephalus, Chiari malformations, trigeminal neuralgia, and traumatic br
The Brain Tumor Biology and Therapy Laboratory studies pediatric and adult high-grade gliomas (HGG)—focusing on brain tumor signing, glioma metabolism and using genomics to identify novel and effective therapies.
The Aird Lab studies the bidirectional interplay between cellular metabolism and the cell cycle in cancer.
The Bailey laboratory focuses on the intersection of DNA damage and immunobiology in Ewing sarcoma, a primary bone tumor diagnosed in adolescents.
Identify phosphorylations, dephosphorylations and acetylations that regulate ATM activity in vivo
The mechanisms of cross-priming of antigens during immune responses to cancer, viruses and autoimmunity
Tumor microenvironment, Cancer stem cells, novel therapeutics for cancer
Development of targeted therapies for KRAS mutant NSCLC; Reactivation of OIS and apoptosis; Mechanisms of acquired resistance to targeted agents
The study of human tumor viruses
Stomal Interactions critical to the survival, growth, and spread of ovarian cancer
The metabolic regulation of T cell function, with a specific focus of those T cells that infiltrate the nutrient-poor tumor microenvironment
The Duncan lab studies liver homeostasis, regeneration, and injury, focusing on the role of hepatic chromosome variations (polyploidy and aneuploidy).
Mechanisms of immune escape and clinical translation to therapeutic cancer immunotherapy trials
Roles of signal transduction pathways, transcription factors, and chromatin epigenetics in pathological changes in osteoclasts and osteoblasts in cancer-induced bone disease and Paget’s disease of bone
Dr. Nadine Hempel's research interests center on understanding molecular mechanisms that regulate metastasis and tumor recurrence of ovarian cancer, with the ultimate goal of identifying novel targets for therapy of advanced-stage disease.
Molecular profiling (genomic, transcriptomic, proteomic) of women’s cancers, mouse modeling, and predictive biomarkers for targeted therapy
The Lohmueller lab works on developing genetic engineering approaches to augment adoptive cell therapy (ACT) for the treatment of cancer.
Liver regeneration and carcinogenesis, exploring the effects of growth factors and associated signaling pathways
Hormone response and treatment resistance in breast and ovarian cancer, including the analysis of aberrant genetic and epigenetic changes
Mechanisms for preserving telomeres in healthy cells to delay aging-related diseases including cancer, or that conversely deplete telomeres in cancer cells to stop their proliferation
Metabolic, molecular and biochemical changes in animal models of pediatric and adult liver cancers and how best to capitalize on these for therapeutic purposes
The goals of the Rich Lab are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core regulatory pathways amenable to pharmacologic targeting.
Studying Epstein-Barr virus molecular pathogenesis in the nasopharynx using 3-D cell air-liquid interface culture models.
Mechanisms of white blood cell differentiation & its inhibition in leukemias; Mechanisms of stem cell differentiation & growth control